WHOResearchInitiativeon

Alcohol,HealthandDevelopment

WHOInternationalCollaborativeResearchProjectonChildDevelopmentand
PrenatalRiskFactorswithaFocusonFetalAlcoholSpectrumDisorders(FASD)

TrainingWorkshopontheProjectImplementation
13October2015,Krakow,Poland

PROVISIONAL AGENDA
1 October 2015, Thursday1
08.30-09.30

Coordination meeting of Principal Investigators

18.30-19.30

Welcome and introduction

2 October 2015, Friday

Session I
08.30-9.30

Overview of the current status of the collaborative research

project on Child Development and Prenatal Risk Exposure
Dr Vladimir Poznyak, World Health Organization (WHO)
Dr Margaret Murray, NIAAA, USA
Dr Lana Popova, CAMH, Canada

Session II
09.30 10.30

Round of short presentations on the project implementation in

represented countries

10.30 11.00

COFFEE BREAK

Session III
11.00-13.00
(in two parallel
groups:
A - dysmorphology
assessment;

Qualitative and quantitative dysmorphology assessment for

FASD identification
Objective: to train participants on principles and methods of
dysmorphology assessment for identifying cases of FASD including
screening procedures.
Expected outcomes: Capacity to conduct dysmorphology assessment.
Dr del Campo

Bneuropsychological Neuropsychological assessment for identifying cases of FASD

assessment)
including screening procedures
Objective: to train participants on principles and methods of
neuropsychological and behavioural assessment for identifying cases
of FASD including screening procedures.
Expected outcomes: Capacity to conduct neuropsychological and
behavioural assessment.
Dr Christie Petrenko
1

During the first day the meeting participants are also expected to attend the international scientific and
educational conference FASD clinical and social problem.

13.00-14.00

LUNCH BREAK

Session IV
(in clinical
setting)
14.00-16.00

Case studies for dysmorphology and neuropsychological and

behavioural assessment in clinical setting - the Saint Ludwik
Childrens Hospital
Objective: to train practical skills of neuropsychological and
behavioural assessment for identifying cases of FASD.
Expected outcomes: practical skills acquired for conducting these
assessments.
Break into four small groups: two in dysmorphology and two in
neuropsychological assessment for examining children.
Drs. Miguel Del Campo and Christie Petrenko

16.00-16.30

COFFEE BREAK

Session V
16.30-17.30

Case study analysis and discussion

17.30 - 17.45

Summary of the day

3 October 2015, Saturday

Session VI
(in clinical
setting)
9.00 - 11.00

Case studies for dysmorphology, neuropsychological and

behavioural assessment in clinical setting - the Saint Ludwik
Childrens Hospital (continuation)
Objective: to train practical skills of dysmorphology and
neuropsychological and behavioural assessment for identifying cases
of FASD.
Expected outcomes: practical skills acquired for conducting these
assessments.
Break into four small groups: two in dysmorphology and two in
neuropsychological assessment for examining children.
Drs. Miguel Del Campo and Christie Petrenko

11.00 11.30

COFFEE BREAK

11:30 12:00

Visit of the Poland Centre for FASD Diagnosis in the Saint

Ludwik Hospital

12.30 13.30

LUNCH BREAK

-2-

Session VII
13.30-14.30

Final discussion on morphological, neuropsychological and

behavioural assessment

Session VIII
14.30-15.30

The WHO International Collaborative Research Project on Child

Development and Prenatal Risk Factors with a Focus on FASD:
Methodology, sampling and assessment procedures
Objective: (i) discuss the implementation of the study protocol
including sampling procedures, screening and diagnostic procedures
and tools, data management, ethical issues and quality assurance
procedures.
Expected outcomes: Good understanding of the study protocol in
represented sites/countries.
Dr. Lana Popova

15.30-16.00

COFFEE BREAK

16.00-17.00

The WHO International Collaborative Research Project on Child

Development and Prenatal Risk Factors with a Focus on FASD:
Methodology, sampling and assessment procedures (continuation)

Session IX
17.00-17.30

Final discussion and closure of the meeting

Dr. Vladimir Poznyak, WHO

-3-